AR024367A1 - Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal. - Google Patents
Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal.Info
- Publication number
- AR024367A1 AR024367A1 ARP000102965A AR024367A1 AR 024367 A1 AR024367 A1 AR 024367A1 AR P000102965 A ARP000102965 A AR P000102965A AR 024367 A1 AR024367 A1 AR 024367A1
- Authority
- AR
- Argentina
- Prior art keywords
- igm
- gangliosides
- purification
- plasma
- antibodies
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 3
- 238000009413 insulation Methods 0.000 title 1
- 210000002966 serum Anatomy 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000002270 gangliosides Chemical class 0.000 abstract 2
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000003196 chaotropic effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En esta presentacion se describe un método para la purificacion de anticuerpos anti-gangliosidos del tipo IgM a partir de plasma humano normal; de IgMpoliespecíficas; o bien de fracciones de proteínas plasmáticas enriquecidas en IgM, como porejemplo de pasta III obtenida segun los métodos 6 y 9 de Cohn-Oncley de fraccionamiento etanolico del plasma; y que incluye, el tratamiento de la muestra con agentes caotropicos para la disociacion de los complejosinmunocirculantes, antígeno(gangliosidos) -anticuerpos (IgM anti-gangliosidos); la posterior precipitacion de las lipoproteínas plasmáticas, eliminado de estemodo a los gangliosidos que son parte integrantes de las mismas; seguido de la obtencion de un preparado rico eninmunoglobulina M; y la purificacion porafinidad de las IgM específicas anti-gangliosidos. Además, las IgM anti-gangliosidos purificadas pueden ser retomadas en un vehículo farmacéutico aceptable, enun volumen tal para obtener altos títulos deanticuerpos anti-gangliosid os, y resultar utiles en terapia inmunologica pasiva en pacientes con cáncer; o bien,para su uso potencial en reactivos diagnosticos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP000102965 AR024367A1 (es) | 2000-06-15 | 2000-06-15 | Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP000102965 AR024367A1 (es) | 2000-06-15 | 2000-06-15 | Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR024367A1 true AR024367A1 (es) | 2002-10-02 |
Family
ID=45570615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102965 AR024367A1 (es) | 2000-06-15 | 2000-06-15 | Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal. |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR024367A1 (es) |
-
2000
- 2000-06-15 AR ARP000102965 patent/AR024367A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McConathy et al. | Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system | |
| DE58900776D1 (de) | Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen. | |
| Milne et al. | Characterization of monoclonal antibodies against human apolipoprotein E. | |
| ATE19792T1 (de) | Verfahren zur herstellung eines kolonspezifischen antigen p tryptischen peptides und von anti-kolon-spezifischen antigen p antikoerpern. | |
| DE69723434D1 (de) | Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope | |
| DE69800716D1 (de) | Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen | |
| PT91856B (pt) | Processo de preparacao de uma matriz com actividade imunomodulante, a base lipido e saponina | |
| BR0209177A (pt) | Anticorpo especìfico a tumor recombinante e uso do mesmo | |
| TR199801722T2 (xx) | Peptit imm�nojenler. | |
| Shorter et al. | Inflammatory bowel disease: cytophilic antibody and the cytotoxicity of lymphocytes for colonic cells in vitro | |
| Curtain et al. | Possible sites of macroglobulin synthesis: a study made with fluorescent antibody | |
| CN102558278B (zh) | 三萜类化合物及其在制备抗补体药物中的用途 | |
| RU2005106841A (ru) | Эпитопы т-клеток в эритропоэтине | |
| AR024367A1 (es) | Procedimiento para el aislamiento y purificacion de anticuerpos anti-glicoesfingolipidos presentes en suero o plasma humano normal. | |
| McFarlane et al. | Antigens of the human liver | |
| ES2097207T3 (es) | Receptor de poli-ig de sintesis, complejos receptor-anticuerpo, produccion y aplicacion de los mismos. | |
| Willard et al. | Association of an axonally transported polypeptide (H) with 100-A filaments. Use of immunoaffinity electron microscope grids. | |
| Dottorini et al. | Echinococcus granulosus: characterization of the main antigenic component (arc 5) of hydatid fluid | |
| DE69636527D1 (de) | Antigenes protein aus malassezia | |
| Sepetjian et al. | Investigation of a specific IgM antibody test in neonatal congenital syphilis | |
| Sheng et al. | In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor | |
| Takamatsu | Phytosphingosine-containing neutral glycosphingolipids and sulfatides in the human female genital tract: their association in the cervical epithelium and the uterine endometrium and their dissociation in the mucosa of fallopian tube with the menstrual cycle | |
| Gu et al. | T cell subpopulations and their functions in vitro: A study in patients with alopecia areata and alopecia universalis | |
| Goldfarb | The present status of studies with ragweed pollen | |
| Santana et al. | Identification of a high molecular weight protein on the surface of murine thymus and thymus‐dependent cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure | ||
| FB | Suspension of granting procedure |